Global Infectious Disease Biomarker Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 08 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Infectious Disease Biomarker Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Infectious Disease Biomarker Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Infectious Disease Biomarker Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Infectious Disease Biomarker Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Infectious Disease Biomarker Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Infectious Disease Biomarker Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Disease Biomarker Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Disease Biomarker Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies and Becton, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Infectious Disease Biomarker Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    PCR
    NGS
    ELISA or EIA
    IHC
    ISH
    Others

Market segment by Application
    Hospitals and Clinics
    Diagnostic Centers
    Academic Research Institutes
    Others

Market segment by players, this report covers
    Abacus Diagnostica
    ALPCO
    Abbott Laboratories
    Agilent Technologies
    Becton
    Dickinson and Company
    bioMérieux SA
    Bio-Rad Laboratories
    Danaher
    F. Hoffmann-La Roche
    Hologic
    PerkinElmer
    Qiagen
    Quest Diagnostics Incorporated
    Siemens Healthineers
    Thermo Fisher Scientific

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Disease Biomarker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Biomarker Testing, with revenue, gross margin and global market share of Infectious Disease Biomarker Testing from 2018 to 2023.
Chapter 3, the Infectious Disease Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Infectious Disease Biomarker Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Biomarker Testing.
Chapter 13, to describe Infectious Disease Biomarker Testing research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Infectious Disease Biomarker Testing
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Infectious Disease Biomarker Testing by Type
        1.3.1 Overview: Global Infectious Disease Biomarker Testing Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Infectious Disease Biomarker Testing Consumption Value Market Share by Type in 2022
        1.3.3 PCR
        1.3.4 NGS
        1.3.5 ELISA or EIA
        1.3.6 IHC
        1.3.7 ISH
        1.3.8 Others
    1.4 Global Infectious Disease Biomarker Testing Market by Application
        1.4.1 Overview: Global Infectious Disease Biomarker Testing Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals and Clinics
        1.4.3 Diagnostic Centers
        1.4.4 Academic Research Institutes
        1.4.5 Others
    1.5 Global Infectious Disease Biomarker Testing Market Size & Forecast
    1.6 Global Infectious Disease Biomarker Testing Market Size and Forecast by Region
        1.6.1 Global Infectious Disease Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Infectious Disease Biomarker Testing Market Size by Region, (2018-2029)
        1.6.3 North America Infectious Disease Biomarker Testing Market Size and Prospect (2018-2029)
        1.6.4 Europe Infectious Disease Biomarker Testing Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Infectious Disease Biomarker Testing Market Size and Prospect (2018-2029)
        1.6.6 South America Infectious Disease Biomarker Testing Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Infectious Disease Biomarker Testing Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Abacus Diagnostica
        2.1.1 Abacus Diagnostica Details
        2.1.2 Abacus Diagnostica Major Business
        2.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product and Solutions
        2.1.4 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abacus Diagnostica Recent Developments and Future Plans
    2.2 ALPCO
        2.2.1 ALPCO Details
        2.2.2 ALPCO Major Business
        2.2.3 ALPCO Infectious Disease Biomarker Testing Product and Solutions
        2.2.4 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 ALPCO Recent Developments and Future Plans
    2.3 Abbott Laboratories
        2.3.1 Abbott Laboratories Details
        2.3.2 Abbott Laboratories Major Business
        2.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product and Solutions
        2.3.4 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Abbott Laboratories Recent Developments and Future Plans
    2.4 Agilent Technologies
        2.4.1 Agilent Technologies Details
        2.4.2 Agilent Technologies Major Business
        2.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product and Solutions
        2.4.4 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Agilent Technologies Recent Developments and Future Plans
    2.5 Becton
        2.5.1 Becton Details
        2.5.2 Becton Major Business
        2.5.3 Becton Infectious Disease Biomarker Testing Product and Solutions
        2.5.4 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Becton Recent Developments and Future Plans
    2.6 Dickinson and Company
        2.6.1 Dickinson and Company Details
        2.6.2 Dickinson and Company Major Business
        2.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product and Solutions
        2.6.4 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Dickinson and Company Recent Developments and Future Plans
    2.7 bioMérieux SA
        2.7.1 bioMérieux SA Details
        2.7.2 bioMérieux SA Major Business
        2.7.3 bioMérieux SA Infectious Disease Biomarker Testing Product and Solutions
        2.7.4 bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 bioMérieux SA Recent Developments and Future Plans
    2.8 Bio-Rad Laboratories
        2.8.1 Bio-Rad Laboratories Details
        2.8.2 Bio-Rad Laboratories Major Business
        2.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Solutions
        2.8.4 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.9 Danaher
        2.9.1 Danaher Details
        2.9.2 Danaher Major Business
        2.9.3 Danaher Infectious Disease Biomarker Testing Product and Solutions
        2.9.4 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Danaher Recent Developments and Future Plans
    2.10 F. Hoffmann-La Roche
        2.10.1 F. Hoffmann-La Roche Details
        2.10.2 F. Hoffmann-La Roche Major Business
        2.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Solutions
        2.10.4 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 F. Hoffmann-La Roche Recent Developments and Future Plans
    2.11 Hologic
        2.11.1 Hologic Details
        2.11.2 Hologic Major Business
        2.11.3 Hologic Infectious Disease Biomarker Testing Product and Solutions
        2.11.4 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Hologic Recent Developments and Future Plans
    2.12 PerkinElmer
        2.12.1 PerkinElmer Details
        2.12.2 PerkinElmer Major Business
        2.12.3 PerkinElmer Infectious Disease Biomarker Testing Product and Solutions
        2.12.4 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 PerkinElmer Recent Developments and Future Plans
    2.13 Qiagen
        2.13.1 Qiagen Details
        2.13.2 Qiagen Major Business
        2.13.3 Qiagen Infectious Disease Biomarker Testing Product and Solutions
        2.13.4 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Qiagen Recent Developments and Future Plans
    2.14 Quest Diagnostics Incorporated
        2.14.1 Quest Diagnostics Incorporated Details
        2.14.2 Quest Diagnostics Incorporated Major Business
        2.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Solutions
        2.14.4 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
    2.15 Siemens Healthineers
        2.15.1 Siemens Healthineers Details
        2.15.2 Siemens Healthineers Major Business
        2.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product and Solutions
        2.15.4 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Siemens Healthineers Recent Developments and Future Plans
    2.16 Thermo Fisher Scientific
        2.16.1 Thermo Fisher Scientific Details
        2.16.2 Thermo Fisher Scientific Major Business
        2.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Solutions
        2.16.4 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Thermo Fisher Scientific Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Infectious Disease Biomarker Testing Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Infectious Disease Biomarker Testing by Company Revenue
        3.2.2 Top 3 Infectious Disease Biomarker Testing Players Market Share in 2022
        3.2.3 Top 6 Infectious Disease Biomarker Testing Players Market Share in 2022
    3.3 Infectious Disease Biomarker Testing Market: Overall Company Footprint Analysis
        3.3.1 Infectious Disease Biomarker Testing Market: Region Footprint
        3.3.2 Infectious Disease Biomarker Testing Market: Company Product Type Footprint
        3.3.3 Infectious Disease Biomarker Testing Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Infectious Disease Biomarker Testing Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Infectious Disease Biomarker Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2018-2023)
    5.2 Global Infectious Disease Biomarker Testing Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Infectious Disease Biomarker Testing Consumption Value by Type (2018-2029)
    6.2 North America Infectious Disease Biomarker Testing Consumption Value by Application (2018-2029)
    6.3 North America Infectious Disease Biomarker Testing Market Size by Country
        6.3.1 North America Infectious Disease Biomarker Testing Consumption Value by Country (2018-2029)
        6.3.2 United States Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        6.3.3 Canada Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        6.3.4 Mexico Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Infectious Disease Biomarker Testing Consumption Value by Type (2018-2029)
    7.2 Europe Infectious Disease Biomarker Testing Consumption Value by Application (2018-2029)
    7.3 Europe Infectious Disease Biomarker Testing Market Size by Country
        7.3.1 Europe Infectious Disease Biomarker Testing Consumption Value by Country (2018-2029)
        7.3.2 Germany Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        7.3.3 France Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        7.3.5 Russia Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        7.3.6 Italy Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region
        8.3.1 Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Region (2018-2029)
        8.3.2 China Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        8.3.3 Japan Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        8.3.4 South Korea Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        8.3.5 India Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        8.3.7 Australia Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Infectious Disease Biomarker Testing Consumption Value by Type (2018-2029)
    9.2 South America Infectious Disease Biomarker Testing Consumption Value by Application (2018-2029)
    9.3 South America Infectious Disease Biomarker Testing Market Size by Country
        9.3.1 South America Infectious Disease Biomarker Testing Consumption Value by Country (2018-2029)
        9.3.2 Brazil Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        9.3.3 Argentina Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country
        10.3.1 Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Country (2018-2029)
        10.3.2 Turkey Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)
        10.3.4 UAE Infectious Disease Biomarker Testing Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Infectious Disease Biomarker Testing Market Drivers
    11.2 Infectious Disease Biomarker Testing Market Restraints
    11.3 Infectious Disease Biomarker Testing Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Infectious Disease Biomarker Testing Industry Chain
    12.2 Infectious Disease Biomarker Testing Upstream Analysis
    12.3 Infectious Disease Biomarker Testing Midstream Analysis
    12.4 Infectious Disease Biomarker Testing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infectious Disease Biomarker Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Infectious Disease Biomarker Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Infectious Disease Biomarker Testing Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Infectious Disease Biomarker Testing Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Abacus Diagnostica Company Information, Head Office, and Major Competitors
    Table 6. Abacus Diagnostica Major Business
    Table 7. Abacus Diagnostica Infectious Disease Biomarker Testing Product and Solutions
    Table 8. Abacus Diagnostica Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Abacus Diagnostica Recent Developments and Future Plans
    Table 10. ALPCO Company Information, Head Office, and Major Competitors
    Table 11. ALPCO Major Business
    Table 12. ALPCO Infectious Disease Biomarker Testing Product and Solutions
    Table 13. ALPCO Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. ALPCO Recent Developments and Future Plans
    Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
    Table 16. Abbott Laboratories Major Business
    Table 17. Abbott Laboratories Infectious Disease Biomarker Testing Product and Solutions
    Table 18. Abbott Laboratories Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Abbott Laboratories Recent Developments and Future Plans
    Table 20. Agilent Technologies Company Information, Head Office, and Major Competitors
    Table 21. Agilent Technologies Major Business
    Table 22. Agilent Technologies Infectious Disease Biomarker Testing Product and Solutions
    Table 23. Agilent Technologies Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Agilent Technologies Recent Developments and Future Plans
    Table 25. Becton Company Information, Head Office, and Major Competitors
    Table 26. Becton Major Business
    Table 27. Becton Infectious Disease Biomarker Testing Product and Solutions
    Table 28. Becton Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Becton Recent Developments and Future Plans
    Table 30. Dickinson and Company Company Information, Head Office, and Major Competitors
    Table 31. Dickinson and Company Major Business
    Table 32. Dickinson and Company Infectious Disease Biomarker Testing Product and Solutions
    Table 33. Dickinson and Company Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Dickinson and Company Recent Developments and Future Plans
    Table 35. bioMérieux SA Company Information, Head Office, and Major Competitors
    Table 36. bioMérieux SA Major Business
    Table 37. bioMérieux SA Infectious Disease Biomarker Testing Product and Solutions
    Table 38. bioMérieux SA Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. bioMérieux SA Recent Developments and Future Plans
    Table 40. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
    Table 41. Bio-Rad Laboratories Major Business
    Table 42. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Solutions
    Table 43. Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Bio-Rad Laboratories Recent Developments and Future Plans
    Table 45. Danaher Company Information, Head Office, and Major Competitors
    Table 46. Danaher Major Business
    Table 47. Danaher Infectious Disease Biomarker Testing Product and Solutions
    Table 48. Danaher Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Danaher Recent Developments and Future Plans
    Table 50. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
    Table 51. F. Hoffmann-La Roche Major Business
    Table 52. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Solutions
    Table 53. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. F. Hoffmann-La Roche Recent Developments and Future Plans
    Table 55. Hologic Company Information, Head Office, and Major Competitors
    Table 56. Hologic Major Business
    Table 57. Hologic Infectious Disease Biomarker Testing Product and Solutions
    Table 58. Hologic Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Hologic Recent Developments and Future Plans
    Table 60. PerkinElmer Company Information, Head Office, and Major Competitors
    Table 61. PerkinElmer Major Business
    Table 62. PerkinElmer Infectious Disease Biomarker Testing Product and Solutions
    Table 63. PerkinElmer Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. PerkinElmer Recent Developments and Future Plans
    Table 65. Qiagen Company Information, Head Office, and Major Competitors
    Table 66. Qiagen Major Business
    Table 67. Qiagen Infectious Disease Biomarker Testing Product and Solutions
    Table 68. Qiagen Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Qiagen Recent Developments and Future Plans
    Table 70. Quest Diagnostics Incorporated Company Information, Head Office, and Major Competitors
    Table 71. Quest Diagnostics Incorporated Major Business
    Table 72. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Solutions
    Table 73. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Quest Diagnostics Incorporated Recent Developments and Future Plans
    Table 75. Siemens Healthineers Company Information, Head Office, and Major Competitors
    Table 76. Siemens Healthineers Major Business
    Table 77. Siemens Healthineers Infectious Disease Biomarker Testing Product and Solutions
    Table 78. Siemens Healthineers Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Siemens Healthineers Recent Developments and Future Plans
    Table 80. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 81. Thermo Fisher Scientific Major Business
    Table 82. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Solutions
    Table 83. Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 85. Global Infectious Disease Biomarker Testing Revenue (USD Million) by Players (2018-2023)
    Table 86. Global Infectious Disease Biomarker Testing Revenue Share by Players (2018-2023)
    Table 87. Breakdown of Infectious Disease Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 88. Market Position of Players in Infectious Disease Biomarker Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 89. Head Office of Key Infectious Disease Biomarker Testing Players
    Table 90. Infectious Disease Biomarker Testing Market: Company Product Type Footprint
    Table 91. Infectious Disease Biomarker Testing Market: Company Product Application Footprint
    Table 92. Infectious Disease Biomarker Testing New Market Entrants and Barriers to Market Entry
    Table 93. Infectious Disease Biomarker Testing Mergers, Acquisition, Agreements, and Collaborations
    Table 94. Global Infectious Disease Biomarker Testing Consumption Value (USD Million) by Type (2018-2023)
    Table 95. Global Infectious Disease Biomarker Testing Consumption Value Share by Type (2018-2023)
    Table 96. Global Infectious Disease Biomarker Testing Consumption Value Forecast by Type (2024-2029)
    Table 97. Global Infectious Disease Biomarker Testing Consumption Value by Application (2018-2023)
    Table 98. Global Infectious Disease Biomarker Testing Consumption Value Forecast by Application (2024-2029)
    Table 99. North America Infectious Disease Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
    Table 100. North America Infectious Disease Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
    Table 101. North America Infectious Disease Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. North America Infectious Disease Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. North America Infectious Disease Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
    Table 104. North America Infectious Disease Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
    Table 105. Europe Infectious Disease Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Europe Infectious Disease Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Europe Infectious Disease Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
    Table 108. Europe Infectious Disease Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
    Table 109. Europe Infectious Disease Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Infectious Disease Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
    Table 112. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
    Table 113. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
    Table 114. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
    Table 115. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Region (2018-2023) & (USD Million)
    Table 116. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value by Region (2024-2029) & (USD Million)
    Table 117. South America Infectious Disease Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
    Table 118. South America Infectious Disease Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
    Table 119. South America Infectious Disease Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
    Table 120. South America Infectious Disease Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
    Table 121. South America Infectious Disease Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. South America Infectious Disease Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Type (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Type (2024-2029) & (USD Million)
    Table 125. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Application (2018-2023) & (USD Million)
    Table 126. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Application (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Country (2018-2023) & (USD Million)
    Table 128. Middle East & Africa Infectious Disease Biomarker Testing Consumption Value by Country (2024-2029) & (USD Million)
    Table 129. Infectious Disease Biomarker Testing Raw Material
    Table 130. Key Suppliers of Infectious Disease Biomarker Testing Raw Materials
List of Figures
    Figure 1. Infectious Disease Biomarker Testing Picture
    Figure 2. Global Infectious Disease Biomarker Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Infectious Disease Biomarker Testing Consumption Value Market Share by Type in 2022
    Figure 4. PCR
    Figure 5. NGS
    Figure 6. ELISA or EIA
    Figure 7. IHC
    Figure 8. ISH
    Figure 9. Others
    Figure 10. Global Infectious Disease Biomarker Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 11. Infectious Disease Biomarker Testing Consumption Value Market Share by Application in 2022
    Figure 12. Hospitals and Clinics Picture
    Figure 13. Diagnostic Centers Picture
    Figure 14. Academic Research Institutes Picture
    Figure 15. Others Picture
    Figure 16. Global Infectious Disease Biomarker Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 17. Global Infectious Disease Biomarker Testing Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 18. Global Market Infectious Disease Biomarker Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 19. Global Infectious Disease Biomarker Testing Consumption Value Market Share by Region (2018-2029)
    Figure 20. Global Infectious Disease Biomarker Testing Consumption Value Market Share by Region in 2022
    Figure 21. North America Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Infectious Disease Biomarker Testing Revenue Share by Players in 2022
    Figure 27. Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 28. Global Top 3 Players Infectious Disease Biomarker Testing Market Share in 2022
    Figure 29. Global Top 6 Players Infectious Disease Biomarker Testing Market Share in 2022
    Figure 30. Global Infectious Disease Biomarker Testing Consumption Value Share by Type (2018-2023)
    Figure 31. Global Infectious Disease Biomarker Testing Market Share Forecast by Type (2024-2029)
    Figure 32. Global Infectious Disease Biomarker Testing Consumption Value Share by Application (2018-2023)
    Figure 33. Global Infectious Disease Biomarker Testing Market Share Forecast by Application (2024-2029)
    Figure 34. North America Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2018-2029)
    Figure 35. North America Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2018-2029)
    Figure 36. North America Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 38. Canada Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 39. Mexico Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 40. Europe Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2018-2029)
    Figure 41. Europe Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2018-2029)
    Figure 42. Europe Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 44. France Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 45. United Kingdom Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 46. Russia Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 47. Italy Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Infectious Disease Biomarker Testing Consumption Value Market Share by Region (2018-2029)
    Figure 51. China Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 52. Japan Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 53. South Korea Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 54. India Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 55. Southeast Asia Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 56. Australia Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 57. South America Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2018-2029)
    Figure 58. South America Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2018-2029)
    Figure 59. South America Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2018-2029)
    Figure 60. Brazil Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 61. Argentina Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 62. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value Market Share by Type (2018-2029)
    Figure 63. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value Market Share by Application (2018-2029)
    Figure 64. Middle East and Africa Infectious Disease Biomarker Testing Consumption Value Market Share by Country (2018-2029)
    Figure 65. Turkey Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 66. Saudi Arabia Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 67. UAE Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 68. Infectious Disease Biomarker Testing Market Drivers
    Figure 69. Infectious Disease Biomarker Testing Market Restraints
    Figure 70. Infectious Disease Biomarker Testing Market Trends
    Figure 71. Porters Five Forces Analysis
    Figure 72. Manufacturing Cost Structure Analysis of Infectious Disease Biomarker Testing in 2022
    Figure 73. Manufacturing Process Analysis of Infectious Disease Biomarker Testing
    Figure 74. Infectious Disease Biomarker Testing Industrial Chain
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific

Related Reports

Global Infectious Disease Biomarker Testing Supply, Demand and Key Producers, 2023-2029

Global Infectious Disease Biomarker Testing Supply, Demand and Key Producers, 2023-2029

date 17 Feb 2023

date Medical Care

The global Infectious Disease Biomarker Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Infectious Disease Biomarker Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Infectious Disease Biomarker Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Infectious Disease Biomarker Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Infectious Disease Biomarker Testing Supply, Demand and Key Producers, 2024-2030

Global Infectious Disease Biomarker Testing Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Medical Care

The global Infectious Disease Biomarker Testing market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Infectious Disease Biomarker Testing

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>